Unovis

About

Portfolio · 5

Oshi

Alternative Protein Seafood

1 round $12.5M committed Latest: 2022-03

Imagindairy

Animal-free Dairy Products

1 round $13.0M committed Latest: 2021-11

SuperMeat

Clean Chicken Meat

2 rounds $5.0M committed Latest: 2020-12

Zero Egg

Plant-based Egg Substitute

2 rounds $6.5M committed Latest: 2020-11

Aleph Farms

Cellular Agriculture Technology

2 rounds $13.3M committed Latest: 2019-05

Investment activity

Funds · 1

• NCAP II — $166M Jan 2022

Q&A

What is Unovis's primary investment focus?

Unovis Asset Management is a venture capital firm founded in 2016, focused on early-stage investments in the alternative protein sector. The firm invests in companies developing plant-based, fungi-based, fermented, and cultivated alternatives to animal products.

Which investment stages does Unovis typically target?

Unovis primarily targets Pre-Seed, Seed, A Round, and B Round investment stages.

Can you name some notable companies in Unovis's portfolio?

Unovis's portfolio includes Aleph Farms, which focuses on cellular agriculture technology, and Imagindairy, which develops animal-free dairy products.

What is the most recent fund raised by Unovis?

Unovis closed its NCAP II fund in January 2022, raising $166 million.

Who are the co-founders of Unovis?

The co-founders of Unovis are Kim Anders Odhner, Dan Altschuler, and Chris Kerr.

Where is Unovis headquartered?

Unovis is headquartered in New York, NY, United States.

What is Unovis's sector concentration?

Unovis shows a strong concentration in the Agriculture & Food Technologies sector, with all five of its listed portfolio companies operating in this area.

Has Unovis made any investments in Israeli companies?

Yes, Dan Altschuler, a Co-founder and Managing Partner, is responsible for North America and Israel, indicating a focus on investments in the Israeli market.